Search research articles
Contact Us
Filters
Showing results (41-50 of 68) with videos related to
Page
of 7
Sort By:
Journal of Chemotherapy (Florence, Italy)
|
March 18, 2008
Biweekly triple combination chemotherapy with gemcitabine, oxaliplatin, levofolinic acid and 5-fluorouracil (GOLF) is a safe and active treatment for patients with inoperable pancreatic cancer
P Correale, F Montagnani, S Miano, et al.
Bone
|
August 15, 2006
Changes in bone turnover and in bone mass in women with breast cancer switched from tamoxifen to exemestane
S Gonnelli, A Cadirni, C Caffarelli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 1, 1996
Delay in progression of bone metastases in breast cancer patients treated with intravenous pamidronate: results from a multinational randomized controlled trial. The Aredia Multinational Cooperative Group
P F Conte, J Latreille, L Mauriac, et al.
Gastroenterology
|
April 1, 1994
Folinic acid and 5-fluorouracil as adjuvant chemotherapy in colon cancer
G Francini, R Petrioli, L Lorenzini, et al.
Cancer
|
January 15, 1996
Comparison between a cisplatin-containing regimen and a carboplatin-containing regimen for recurrent or metastatic bladder cancer patients. A randomized phase II study
R Petrioli, B Frediani, A Manganelli, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 1, 1994
Ovarian ablation versus goserelin with or without tamoxifen in pre-perimenopausal patients with advanced breast cancer: results of a multicentric Italian study
F Boccardo, A Rubagotti, A Perrotta, et al.
British Journal of Cancer
|
September 17, 2002
Weekly epirubicin in patients with hormone-resistant prostate cancer
R Petrioli, A I Fiaschi, D Pozzessere, et al.
Biochemical Society Transactions
|
February 1, 1996
Endo 5'-nucleotidase in healthy peripheral blood lymphocytes. Inhibition by alpha beta methylene adenosine 5'-diphosphate
M Pizzichini, E Marinello, F Rosi, et al.
Cardiologia (Rome, Italy)
|
November 1, 1982
[Ischemic cardiomyopathy, catecholamines and cyclic nucleotides]
C Gennari, R Nami, C Giustarini, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 12, 2003
Gemcitabine increases systemic 5-fluorouracil exposure in advanced cancer patients
P Correale, D Cerretani, S Marsili, et al.
Page
of 7
Search research articles
Search
Showing results (41-50 of 68) with videos related to
Sort By:
Page
of 7
Journal of Chemotherapy (Florence, Italy)
|
March 18, 2008
Biweekly triple combination chemotherapy with gemcitabine, oxaliplatin, levofolinic acid and 5-fluorouracil (GOLF) is a safe and active treatment for patients with inoperable pancreatic cancer
P Correale, F Montagnani, S Miano, et al.
Bone
|
August 15, 2006
Changes in bone turnover and in bone mass in women with breast cancer switched from tamoxifen to exemestane
S Gonnelli, A Cadirni, C Caffarelli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 1, 1996
Delay in progression of bone metastases in breast cancer patients treated with intravenous pamidronate: results from a multinational randomized controlled trial. The Aredia Multinational Cooperative Group
P F Conte, J Latreille, L Mauriac, et al.
Gastroenterology
|
April 1, 1994
Folinic acid and 5-fluorouracil as adjuvant chemotherapy in colon cancer
G Francini, R Petrioli, L Lorenzini, et al.
Cancer
|
January 15, 1996
Comparison between a cisplatin-containing regimen and a carboplatin-containing regimen for recurrent or metastatic bladder cancer patients. A randomized phase II study
R Petrioli, B Frediani, A Manganelli, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 1, 1994
Ovarian ablation versus goserelin with or without tamoxifen in pre-perimenopausal patients with advanced breast cancer: results of a multicentric Italian study
F Boccardo, A Rubagotti, A Perrotta, et al.
British Journal of Cancer
|
September 17, 2002
Weekly epirubicin in patients with hormone-resistant prostate cancer
R Petrioli, A I Fiaschi, D Pozzessere, et al.
Biochemical Society Transactions
|
February 1, 1996
Endo 5'-nucleotidase in healthy peripheral blood lymphocytes. Inhibition by alpha beta methylene adenosine 5'-diphosphate
M Pizzichini, E Marinello, F Rosi, et al.
Cardiologia (Rome, Italy)
|
November 1, 1982
[Ischemic cardiomyopathy, catecholamines and cyclic nucleotides]
C Gennari, R Nami, C Giustarini, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 12, 2003
Gemcitabine increases systemic 5-fluorouracil exposure in advanced cancer patients
P Correale, D Cerretani, S Marsili, et al.
Page
of 7